Topics

Parkinson's disease | Treatment | Clinical trials | Stem cell transplantation

Home > Publications > Topics > Parkinson's disease > Treatment > Clinical trials > Stem cell transplantation

Paul G, Bjartmarz H, Kirkeby A, Nelander J, Smith R, Kayhanian S, Evans A, Harry B, Cutting E, Fazal S, Lao-Kaim NP, van Vliet T, Ullén S, Grubor I, Hansson O, Piccini P, Lindvall O, Björklund A, Widner H, Parmar M, Barker RA.
Human embryonic stem cell-derived dopaminergic cells for Parkinson's disease: a phase 1/2 open-label trial.
Nat Med. 2026 Jul 9. doi: 10.1038/s41591-026-04525-0. PMID: 42426223. Trial registration ID: NCT05635409. ˍ News